This lecture reviews the mechanisms and clinical trial evidence for antithrombotic agents, highlighting the role of clopidogrel and GPIIb/IIIa inhibitors in managing atherosclerotic vascular disease and acute coronary syndromes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Marc Verstraete (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: